AstraZeneca's Covid-19 vaccine shows 76 per cent efficacy in updated US trial results

Following the doubts expressed by a top US-based health agency over the Covid-19 vaccine trial data, British-Swedish drugmaker AstraZeneca has shared the primary analysis of its vaccine with the most up-to-date data. It said that the COVID-19 vaccine is 76 per cent effective.

Following the doubts expressed by a top US-based health agency over the Covid-19 vaccine trial data, British-Swedish drugmaker AstraZeneca has shared the primary analysis of its vaccine with the most up-to-date data. It said that the COVID-19 vaccine is 76 per cent effective. March 25, 2021 at 09:03AM https://ift.tt/3d8sG5B